This study collects information about how radiofrequency ablation (RFA) for dysplastic Barrett’s esophagus (BE) and esophageal cancer affects the flexibility/elasticity of the esophagus, as well as esophageal lining integrity/damage.
Additional locations may be listed on ClinicalTrials.gov for NCT07126535.
Locations matching your search criteria
United States
Minnesota
Rochester
Mayo Clinic in RochesterStatus: Active
Contact: Chamil C. Codipilly
Phone: 507-284-4823
PRIMARY OBJECTIVES:
I. Determine how the distensibility of the distal esophagus is impacted by a course of ablative therapy.
II. Determine how mucosal permeability, as measured by mucosal impedance, changes over the course of ablative therapy.
OUTLINE: This is an observational study.
Patients undergo measurement of esophageal flexibility/elasticity and mucosal impedance using EndoFLIP and MiVU during upper endoscopy and complete questionnaires on study.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationMayo Clinic in Rochester
Principal InvestigatorChamil C. Codipilly
